ProPhase Labs Announces Preliminary Positive Results for Dietary Supplement Equivir
14 févr. 2024 08h00 HE
|
ProPhase Labs, Inc.
Commercialization of Equivir anticipated after second trial is completed in Q2, 2024 Garden City, NY, Feb. 14, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a next generation...